AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer

BACKGROUND: Gastric cancer (GC) is one of the most common cancers worldwide with a poor prognosis. The tumor microenvironment (TME) serves a pivotal role in affecting the prognosis and efficacy of immunotherapy. Given the poor prognosis of GC patients and the limitation of immunotherapy, we urged to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yuling, Zhang, Xueping, Li, Fazhan, Wang, Ying, Wei, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169183/
https://www.ncbi.nlm.nih.gov/pubmed/35478418
http://dx.doi.org/10.1002/jcla.24437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169183/
https://www.ncbi.nlm.nih.gov/pubmed/35478418
http://dx.doi.org/10.1002/jcla.24437

Ejemplares similares